Visgenx Appoints William Pedranti as Chief Executive Officer
The Company is developing VGX-0111, a gene therapy candidate for Dry Age-related Macular Degeneration (AMD), an aging related disorder and a leadi...
Stay updated with breaking news from Chief Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Company is developing VGX-0111, a gene therapy candidate for Dry Age-related Macular Degeneration (AMD), an aging related disorder and a leadi...
The menswear label taps UHNWI's adventurer spirit with a Galápagos campaign, following record-high revenue in 2022. Bigger successes can be expected this year.
/PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists...
Research from Mayo Clinic and UCSF find that the combination of Transpara Exam Score with Volpara TruDensity can predict long-term risk of invasive breast cancers
Research from Mayo Clinic and UCSF find that the combination of Transpara ® Exam Score with Volpara TruDensity® can predict long-term risk of invasive breast cancers NIJMEGEN, Netherlands